Drug Profile
Research programme: 11-beta hydroxysteroid dehydrogenase type-1 inhibitors - Equis & Zaroo
Alternative Names: EQ-1280Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator EQUIS & ZAROO
- Class
- Mechanism of Action 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-mellitus in South Korea
- 24 Mar 2011 Preclinical trials in Diabetes mellitus in South Korea (unspecified route)